These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16570761)

  • 1. Epidemiological aspects of prediabetes--review of the current data.
    Zargar AH; Bashir MI
    J Indian Med Assoc; 2005 Nov; 103(11):591-3. PubMed ID: 16570761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of prediabetes.
    Bhansali A; Dutta P
    J Indian Med Assoc; 2005 Nov; 103(11):594-5, 599. PubMed ID: 16570762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy in prediabetes.
    Mukhopadhyay P; Chowdhury S
    J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
    DeFronzo RA; Abdul-Ghani M
    Am J Cardiol; 2011 Aug; 108(3 Suppl):3B-24B. PubMed ID: 21802577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G; Hancu N
    Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
    Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
    Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequacies of absolute threshold levels for diagnosing prediabetes.
    Bergman M
    Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes.
    Su Y; Liu XM; Sun YM; Jin HB; Fu R; Wang YY; Wu Y; Luan Y
    Int J Clin Pract; 2008 Jun; 62(6):877-82. PubMed ID: 18479281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediabetes: the importance of early identification and intervention.
    Hsueh WA; Orloski L; Wyne K
    Postgrad Med; 2010 Jul; 122(4):129-43. PubMed ID: 20675976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?
    Cali AM; Caprio S
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):123-7. PubMed ID: 18316946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediabetes - 2009].
    Rybka J
    Vnitr Lek; 2009 Sep; 55(9):819-26. PubMed ID: 19785383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of diabetes in cardiovascular disease.
    Cherian B; Meka N; Katragadda S; Arora R
    Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.